Katherine L. Nathanson,, MD, Chief Oncogenomics Physician at the Abramson Cancer Center, considers the role of  family and personal history in the context of screening protocols for the diagnosis of inherited disease and tumor sequencing in the determination of optimal treatment decisions for cancer. Dr. Nathanson also reflects on how the  important information gathered through precision medicine is communicated to family members.